ICD-10 Code for breast cancer
The ICD-10-CM code for breast cancer is C50.919 when documented without further specification. HCC RxHCC Malignant neoplasm of the breast codes in category C50. C50.919 is an unspecified site of an unspecified female breast. Code selection is driven by the specific site within the breast (e.g., nipple/areola C50.0-, central portion C50.1-), the sex (female vs male), and laterality (right, left).
C50.919 is a risk-adjusting diagnosis under CMS-HCC and RxHCC models. Create a free account to see model versions, RAF contribution, and AI-powered HCC suppression analysis.
Which Code Should You Use?
What to Document
- The specific site within the breast (e.g., nipple/areola C50.0-, central portion C50.1-, or another quadrant).
- Sex - female (C50.01-, C50.11-) versus male (C50.02-) breast, which is part of the code.
- Laterality - right versus left breast (e.g., C50.011 right female, C50.012 left female).
- The histology/morphology as documented by pathology.
Common Documentation Pitfalls
- Do not leave breast cancer at the unspecified-site C50.919 when the breast site, sex, and laterality are documented - a specific C50 code applies.
- Sex and laterality are built into the C50 codes - confirm both (e.g., right female C50.011 vs right male C50.021).
Coding Notes
C50.919 is malignant neoplasm of an unspecified site of an unspecified female breast. The specific breast site (nipple/areola C50.0-, central portion C50.1-), sex (female vs male), and laterality (right, left) each drive a more specific C50 code, so the unspecified default should be rare when the record is complete.
Prevalence & Statistics
- An estimated 321,910 new cases of female breast cancer will be diagnosed in the United States in 2026, and an estimated 42,140 people will die of the disease. (NCI SEER Cancer Stat Facts: Female Breast Cancer, 2026)